SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
JAZZ PHARMACEUTICALS
(NQNM:JAZZ Last Sale: 108.73 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (JAZZ : $108.73)
$6,017,879 million Market Cap at Market Close, July 1, 2022
Employs 228.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
3180 Porter Drive Research Report Earnings Snapshot - Last 11/04/18
Palo Alto, CA 94304 Fact Sheet
Phone: 650-496-3777 Financial Statements
Peer Comparison
Annual Reports

Bruce C. Cozadd, Chmn./CEO, Robert M. Myers, Pres., Kathryn E. Falberg, CFO
Focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. IPO at $18 May 31, 2007. Raised $108 million, selling 6 million shares, 24% of the outstanding. Lead Manager: Morgan Stanley.
Historical Charts    Technical Analysis
No Historical Data available for JAZZ

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common JAZZ $108.73 $108.73 0 .0 $106.77 $110.12 470,290 $106.77 $110.12 55,346,997
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex